#United States #Houston #financial results #Nutex Health #Q1 2026

Nutex Health Reports Q1 2026 Financial Performance

Nutex Health Inc. (NASDAQ: NUTX) has announced its financial results for the first quarter ending March 31, 2026, showcasing a robust increase in revenue and net income. This physician-led healthcare services organization operates 27 hospital facilities across 12 states and remains focused on expanding its impact in the healthcare sector.

In the first three months of 2026, Nutex Health reported a total revenue rise of 2.2%, reaching $216.5 million, compared to $211.8 million during the same period last year. This upward trend was largely driven by the hospital division, where revenue grew by 1.8% to $207.6 million, up from $203.9 million in the previous year's first quarter. Notably, revenue at the same hospitals saw a slight increase of 0.2%. This reflects the company's continued commitment to improving patient care and operational efficiency.

The company’s net income surged to $46.8 million or $6.52 in diluted earnings per share (EPS), marking a significant increase from $21.2 million or $3.33 in diluted EPS reported in the first quarter of 2025. The adjusted EBITDA was reported at $57.6 million, indicating a year-over-year decline from $72.8 million but demonstrates Nutex's stability amidst evolving market conditions.

“After a powerful start to 2026, we are excited about the solid revenue growth we have achieved,” stated Jon Bates, Chief Financial Officer of Nutex Health. “Our operating cash flow of $75.5 million underscores our strong financial health and positions us well for planned expansions, including three new hospital openings later this year.” The company's balance sheet remains strong, with a record high cash balance of $207.3 million.

Dr. Tom Vo, Chairman and CEO, elaborated on the ongoing improvements in internal processes and significant investments aimed at boosting patient volumes and admissions further. The strategic decision to target opening three to five new hospitals each year was also reaffirmed, ensuring a sustainable growth trajectory.

Significantly, Nutex Health's innovative operational approach has led to substantial revenue generation from higher acuity claims. Over 50% of its claims have been submitted for Independent Dispute Resolution (IDR), with an impressive success rate above 85%. The company has effectively capitalized on favorable arbitration outcomes, further enhancing its revenue streams.

As of March 31, 2026, Nutex reported total visits at the hospital division rose by 3.1% year over year, marking a total of 49,742 visits, with a modest 0.6% increase at the same hospitals. This reflects the effectiveness of the company's focus on quality care and innovative health solutions.

The Q1 financial results demonstrate not just an operational success but also a strategic positioning for growth. Nutex Health aims to solidify its presence in the healthcare market further with its planned expansion and ongoing operational enhancements.

For stakeholders and analysts, the full financial report is accessible through the U.S. Securities and Exchange Commission, highlighting detailed metrics and insight into the company’s progress.

With the conference call slated for May 1, 2026, Nutex Health is set to provide deeper insights into its quarterly performance and future strategies, inviting participation from investors and interested parties who wish to delve into the company’s plans.

In conclusion, Nutex Health Inc. has set a solid foundation for growth in 2026, with substantial financial performance in Q1 showing promise for future expansions. The leadership's commitment to quality, operational excellence, and strategic growth positions the company well for sustained success in the evolving healthcare landscape.